Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Abeona Therapeutics Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ABEO: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2541+16
Shares1.19M8.17M+6.98M (+584.9%)
Value$3.62M$28.5M+$24.9M (+688.9%)

New holders (19)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ABEO in Q4 2022
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC272,731$4.19M0.38%
Point72 Asset Management, L.P.1,150,648$3.54M0.01%
Armistice Capital, LLC1,106,000$3.41M0.09%
EcoR1 Capital, LLC1,086,956$3.35M0.10%
Deerfield Management Company, L.P. (Series C)869,565$2.68M0.06%
Goldman Sachs Group Inc169,661$522.6K0.00%
Knott David M Jr150,000$462.0K0.20%
Millennium Management LLC147,779$455.0K0.00%
Altium Capital Management LP108,696$334.8K0.17%
ExodusPoint Capital Management, LP94,171$290.0K0.00%
XTX Topco Ltd51,888$159.8K0.03%
Jane Street Group, LLC37,401$115.2K0.00%
Creative Planning20,011$61.6K0.00%
Dark Forest Capital Management LP2,764$8.51K0.00%
Rockefeller Capital Management L.P.1,500$4.00K0.00%
UBS Group AG967$2.98K0.00%
Money Concepts Capital Corp200$6160.00%
Truvestments Capital LLC51$1570.00%
Bank of America Corp32$980.00%

Sold out (3)

Institutions that held Abeona Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ABEO in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Knoll Capital Management, LLC88,629$269.0K
Group One Trading, L.P.3,497$11.0K
BNP Paribas Arbitrage, SA4$12